Liver Cirrhosis Network Cohort Study
NCT05740358 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1222
Last updated 2026-01-13
Summary
Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.
Conditions
- Cirrhosis
- Cirrhosis, Liver
- Cirrhosis Early
- Cirrhosis Due to Hepatitis B
- Cirrhosis Advanced
- Cirrhosis Infectious
- Cirrhosis Alcoholic
- Cirrhosis, Biliary
- Cirrhosis Cryptogenic
- Cirrhosis Due to Hepatitis C
- Cirrhosis Due to Primary Sclerosing Cholangitis
- Autoimmune Hepatitis
Sponsors & Collaborators
-
The Cleveland Clinic
collaborator OTHER - collaborator OTHER
-
Weill Medical College of Cornell University
collaborator OTHER - collaborator OTHER
- collaborator OTHER
-
University of Miami
collaborator OTHER - collaborator OTHER
-
University of California, San Diego
collaborator OTHER -
University of California, San Francisco
collaborator OTHER -
LAC+USC Medical Center
collaborator OTHER -
Virginia Commonwealth University
collaborator OTHER -
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
collaborator NIH -
National Cancer Institute (NCI)
collaborator NIH -
University of Southern California
collaborator OTHER -
Central Virginia Veterans Healthcare System
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Abigail Smith · Northwestern University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-18
- Primary Completion
- 2030-10-24
- Completion
- 2030-10-24
Countries
- United States
Study Locations
More Related Trials
-
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
NCT00867243 ·Status: TERMINATED
-
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients
NCT03965260 ·Status: COMPLETED
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
A Study of the Intestinal Microbiome in Patients with Cirrhosis
NCT06808698 ·Status: NOT_YET_RECRUITING
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.
NCT00213707 ·Status: UNKNOWN
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C
NCT00638144 ·Status: UNKNOWN
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure
NCT05909319 ·Status: UNKNOWN
-
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
NCT05750498 ·Status: RECRUITING
-
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
NCT01428700 ·Status: COMPLETED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis
NCT04195724 ·Status: UNKNOWN ·Phase: NA
-
Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening
NCT00359099 ·Status: TERMINATED
-
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
NCT02877199 ·Status: COMPLETED
-
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
NCT05865691 ·Status: RECRUITING
-
French National MICMAF Cohort
NCT05895890 ·Status: RECRUITING
-
Prospective Studies on Immunopathogenesis of Liver Fibrosis
NCT04943978 ·Status: RECRUITING
-
Predictors of Spontaneous Bacterial Peritonitis Among Patients with Cirrhosis
NCT06884306 ·Status: NOT_YET_RECRUITING